News
06-22-2021, 10:18 PM
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new discoveries.
More... (https://www.news-medical.net/news/20210622/Combination-of-SFRP2-and-PD-1-immunotherapy-halts-aggressive-metastatic-cancer-in-preclinical-model.aspx)
More... (https://www.news-medical.net/news/20210622/Combination-of-SFRP2-and-PD-1-immunotherapy-halts-aggressive-metastatic-cancer-in-preclinical-model.aspx)